Med-Tech Innovation December 22, 2023
Persistent regulatory ambiguity and NHS procurement processes are risking the deprioritisation of the UK market for healthtech innovation, the latest survey of the industry reveals.
The data, captured by the Association of British HealthTech Industries (ABHI) and CPI, highlights that these barriers are now having a tangible impact on the ability of the sector to bring healthtech to the UK.
The regulatory uncertainty experienced has now led to almost half of businesses removing products from the UK market, and over a third of companies have chosen not to bid on specific tenders due to unworkable procurement requirements. Challenges have also been compounded by cost pressures to businesses, with over 77% of respondents highlighting that the cost to serve the...
Today's Sponsors
Today's Sponsor